The replacement of a IgG ELISA assay with an SPR-based test can shorten the production workflow by one day.
Silke Fetzer
Advertisement
Articles by Silke Fetzer
Advertisement
Latest Updated Articles
- Optimized Vaccine Development and Manufacturing: A Technology Overview
Published: January 2nd 2008 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Everything to Know About Cell and Gene Therapy in 2025
2
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
3
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
4
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
5
